Activation of the NFκB Pathway Enhances AhR Expression in Intestinal Caco-2 Cells
Author(s) -
Serge Champion,
Christophe Sauzet,
Patricia Brémond,
Benbrahim Karim,
Juan G. Abraldeṣ,
Eric Sérée,
Y. Barra,
P.H. Villard
Publication year - 2013
Publication title -
isrn toxicology
Language(s) - English
Resource type - Journals
eISSN - 2090-6196
pISSN - 2090-6188
DOI - 10.1155/2013/792452
Subject(s) - inflammation , proinflammatory cytokine , inflammatory bowel disease , caco 2 , nf κb , chemistry , cancer research , microbiology and biotechnology , biology , immunology , in vitro , medicine , biochemistry , disease
Recent data suggest that apart from its well-known role in the regulation of xenobiotic metabolizing enzymes, AhR is also involved in inflammation. However, the influence of inflammation on AhR expression remains unknown. Here, we demonstrated that proinflammatory conditions induced by either PMA or IL-1 β enhance AhR expression in Caco-2 cells. This was associated with an increase in AhR promoter activity. By means of directed mutagenesis experiments and the use of proteasome inhibitors, we demonstrated that inflammation-induced AhR expression involved the NF κ B pathway but not AP-1. Moreover, conditioned media from PMA-treated Caco-2 cells were also able to induce AhR expression, and this induction was repressed by anti-IL-1 β blocking antibodies. Similar results were obtained with conditioned media from PMA-treated THP-1 cells. Taken together, these data suggest that AhR could be involved in vivo in an inflammatory loop. AhR was recently suspected to be implicated in inflammatory bowel disease. Our results support this hypothesis and suggest that AhR could be a new target for inflammatory bowel disease patient management.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom